Literature DB >> 21429549

N-linked glycosylation of dengue virus NS1 protein modulates secretion, cell-surface expression, hexamer stability, and interactions with human complement.

Pawit Somnuke1, Richard E Hauhart, John P Atkinson, Michael S Diamond, Panisadee Avirutnan.   

Abstract

Dengue virus (DENV) NS1 is a versatile non-structural glycoprotein that is secreted as a hexamer, binds to the cell surface of infected and uninfected cells, and has immune evasive functions. DENV NS1 displays two conserved N-linked glycans at N130 and N207. In this study, we examined the role of these two N-linked glycans on NS1 secretion, stability, and function. Because some groups have reported reduced yields of infectious DENV when N130 and N207 are changed, we analyzed glycosylation-deficient NS1 phenotypes using a transgenic expression system. We show that the N-linked glycan at position 130 is required for stabilization of the secreted hexamer whereas the N-linked glycan at residue 207 facilitates secretion and extracellular protein stability. Moreover, NS1 mutants lacking an N-linked glycan at N130 did not interact efficiently with complement components C1s and C4. In summary, our results elucidate the contribution of N-linked glycosylation to the function of DENV NS1.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21429549      PMCID: PMC3089955          DOI: 10.1016/j.virol.2011.02.022

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  55 in total

1.  Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies.

Authors:  Veysel Kayser; Naresh Chennamsetty; Vladimir Voynov; Kurt Forrer; Bernhard Helk; Bernhardt L Trout
Journal:  Biotechnol J       Date:  2011-01       Impact factor: 4.677

2.  Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections.

Authors:  Sophie Alcon; Antoine Talarmin; Monique Debruyne; Andrew Falconar; Vincent Deubel; Marie Flamand
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases.

Authors:  M Krych-Goldberg; R E Hauhart; V B Subramanian; B M Yurcisin; D L Crimmins; D E Hourcade; J P Atkinson
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

4.  Purification and properties of an endo-beta-N-acetylglucosaminidase from Streptomyces griseus.

Authors:  A L Tarentino; F Maley
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

5.  Antibodies from dengue patient sera cross-react with endothelial cells and induce damage.

Authors:  Chiou-Feng Lin; Huan-Yao Lei; Ai-Li Shiau; Ching-Chuan Liu; Hsiao-Sheng Liu; Trai-Ming Yeh; Shun-Hua Chen; Yee-Shin Lin
Journal:  J Med Virol       Date:  2003-01       Impact factor: 2.327

6.  Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction.

Authors:  M G Jacobs; P J Robinson; C Bletchly; J M Mackenzie; P R Young
Journal:  FASEB J       Date:  2000-08       Impact factor: 5.191

7.  Production of anti-dengue NS1 monoclonal antibodies by DNA immunization.

Authors:  Chunya Puttikhunt; Watchara Kasinrerk; Supa Srisa-ad; Thaneeya Duangchinda; Waraporn Silakate; Seangdeun Moonsom; Nopporn Sittisombut; Prida Malasit
Journal:  J Virol Methods       Date:  2003-04       Impact factor: 2.014

8.  An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients.

Authors:  P R Young; P A Hilditch; C Bletchly; W Halloran
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

9.  High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever.

Authors:  Daniel H Libraty; Paul R Young; Darren Pickering; Timothy P Endy; Siripen Kalayanarooj; Sharone Green; David W Vaughn; Ananda Nisalak; Francis A Ennis; Alan L Rothman
Journal:  J Infect Dis       Date:  2002-09-16       Impact factor: 5.226

10.  Facilitation of cell adhesion by immobilized dengue viral nonstructural protein 1 (NS1): arginine-glycine-aspartic acid structural mimicry within the dengue viral NS1 antigen.

Authors:  Hsin-Hou Chang; Huey-Fen Shyu; Yo-Ming Wang; Der-Shan Sun; Rong-Hwa Shyu; Shiao-Shek Tang; Yao-Shine Huang
Journal:  J Infect Dis       Date:  2002-08-28       Impact factor: 5.226

View more
  48 in total

1.  Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease.

Authors:  Justin M Richner; Brett W Jagger; Chao Shan; Camila R Fontes; Kimberly A Dowd; Bin Cao; Sunny Himansu; Elizabeth A Caine; Bruno T D Nunes; Daniele B A Medeiros; Antonio E Muruato; Bryant M Foreman; Huanle Luo; Tian Wang; Alan D Barrett; Scott C Weaver; Pedro F C Vasconcelos; Shannan L Rossi; Giuseppe Ciaramella; Indira U Mysorekar; Theodore C Pierson; Pei-Yong Shi; Michael S Diamond
Journal:  Cell       Date:  2017-07-13       Impact factor: 41.582

2.  Molecular Docking Based Screening of Plant Flavonoids as Dengue NS1 Inhibitors.

Authors:  Muhammad Tahir Ul Qamar; Arooj Mumtaz; Rabbia Naseem; Amna Ali; Tabeer Fatima; Tehreem Jabbar; Zubair Ahmad; Usman Ali Ashfaq
Journal:  Bioinformation       Date:  2014-07-22

3.  Structural basis of Flavivirus NS1 assembly and antibody recognition.

Authors:  Melissa A Edeling; Michael S Diamond; Daved H Fremont
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-04       Impact factor: 11.205

Review 4.  Novel approaches to flavivirus drug discovery.

Authors:  Carolyn Botting; Richard J Kuhn
Journal:  Expert Opin Drug Discov       Date:  2012-03-22       Impact factor: 6.098

5.  Secreted NS1 Protects Dengue Virus from Mannose-Binding Lectin-Mediated Neutralization.

Authors:  Somchai Thiemmeca; Chamaiporn Tamdet; Nuntaya Punyadee; Tanapan Prommool; Adisak Songjaeng; Sansanee Noisakran; Chunya Puttikhunt; John P Atkinson; Michael S Diamond; Alongkot Ponlawat; Panisadee Avirutnan
Journal:  J Immunol       Date:  2016-10-19       Impact factor: 5.422

6.  Critical role of Dengue Virus NS1 protein in viral replication.

Authors:  Jingjing Fan; Yi Liu; Zhiming Yuan
Journal:  Virol Sin       Date:  2014-05-26       Impact factor: 4.327

7.  Impact of glycosylation on stability, structure and unfolding of soybean agglutinin (SBA): an insight from thermal perturbation molecular dynamics simulations.

Authors:  Swagata Halder; Avadhesha Surolia; Chaitali Mukhopadhyay
Journal:  Glycoconj J       Date:  2015-06-16       Impact factor: 2.916

8.  Transposon Mutagenesis of the Zika Virus Genome Highlights Regions Essential for RNA Replication and Restricted for Immune Evasion.

Authors:  Benjamin O Fulton; David Sachs; Megan C Schwarz; Peter Palese; Matthew J Evans
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

Review 9.  Secretion of Nonstructural Protein 1 of Dengue Virus from Infected Mosquito Cells: Facts and Speculations.

Authors:  Ana C Alcalá; Laura A Palomares; Juan E Ludert
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

10.  Optimized protocol for expression and purification of membrane-bound PglB, a bacterial oligosaccharyl transferase.

Authors:  Marcie B Jaffee; Barbara Imperiali
Journal:  Protein Expr Purif       Date:  2013-04-12       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.